DALY II USA/ MB-CART2019.1 for DLBCL
A phase 2 trial of Zamtocabtagene autoleucel, Cyclophosphamide, Fludarabine in diffuse large b-cell lymphoma and mantle cell lymphoma, run by Miltenyi Biomedicine GmbH, now recruiting.
Overview
DALY II USA/ MB-CART2019.1 for DLBCL is a phase 2 interventional study registered as NCT04792489 by Miltenyi Biomedicine GmbH, with 315 participants planned, started 2021-05-25 and due to reach its primary completion in 2026-12-31. Interventions recorded: zamtocabtagene autoleucel (MB-CART2019.1), Cyclophosphamide, Fludarabine, Bendamustine. Conditions listed: Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma, High Grade B-cell Lymphoma (HGBCL), Primary Mediastinal B-cell Lymphoma (PMBCL). No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialDALY II Japan/MB-CART2019.1 for DLBCL
Shares Miltenyi Biomedicine, Zamtocabtagene autoleucel, Diffuse large B-cell lymphoma.
- TrialEfficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Shares Miltenyi Biomedicine, Zamtocabtagene autoleucel, Bendamustine, Diffuse large B-cell lymphoma.
- TrialSafety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms
- TrialA Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
Shares Bendamustine, Fludarabine, Cyclophosphamide.
- TrialStudy of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic L
Shares Fludarabine, Mantle cell lymphoma, Cyclophosphamide.
- TrialPhase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)
Shares Bendamustine, Fludarabine.
- TrialStudy of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients
Shares Fludarabine, Cyclophosphamide, Diffuse large B-cell lymphoma.
- TrialBiomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
Shares Fludarabine, Cyclophosphamide.